Geographic and ethnicity variation in the prevalence of middle‐aged and elderly adult obesity in China in 2020
Diabetes, Obesity and Metabolism · 2024-05 · 26 (5) · 1897-1907
DOI: 10.1111/dom.15506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 21.02.2024. Verfasst von Wen-Jun Tu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Obesity, Abdominal, Ethnicity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Major Public Health Service Projects, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Aim
The objective of this study is to evaluate the mean body mass index (BMI), general obesity and abdominal obesity in adults aged ≥40 years residing in China in 2020, and to analyse variations in these factors across different geographic areas and subpopulations.
Methods
We utilized data from the National Stroke High‐Risk Population Screening programme to calculate and compare the mean BMI and prevalence of obesity across various demographics, including sex, age, urban‐rural locality, geographical region (province) and ethnicity status.
Results
In our study, we found that the standardized mean BMI level was 24.65 kg/m 2 [95% confidence interval (CI): 24.50‐22.84] in men and 24.31 kg/m 2 (95% CI: 24.15‐24.45) in women. Using the criteria from China, we found that the standardized prevalence of general obesity and abdominal obesity was 13.13% (95% CI: 13.05‐13.21%) and 33.03% (95 CI: 32.92‐33.14%), respectively. Our study also identified significant effects of age, sex, urban‐rural locality, province and ethnicity status on the prevalence of obesity. Overall, our study estimated that in 2020, approximately 91.1 million adults aged ≥40 years in China were obese (46.5 million men and 44.6 million women), while 229.2 million adults (110.4 million men and 118.8 million women) were diagnosed with abdominal obesity.
Conclusion
Our research has revealed compelling new evidence about the obesity epidemic among Chinese adults aged ≥40 years, particularly at the provincial and ethnic levels. As a result, more targeted and effective prevention strategies should be developed to alleviate the burden of obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Rehabilitation Hospital of the National Research Center for Rehabilitation Technical Aids, Beijing, China.
- Geriatrics Innovation Center, Weifang People's Hospital, Weifang, China.
- Department of Neurology, Aerospace Center Hospital, Beijing, China.
ORCID-Profile: Wen-Jun Tu
Förderung
- National Major Public Health Service Projects
- China Postdoctoral Science Foundation
Zitieren
APA
Tu, W. J., Zhao, Z., Yan, F., Zeng, X., & Li, J. (2024). Geographic and ethnicity variation in the prevalence of middle‐aged and elderly adult obesity in China in 2020. Diabetes, Obesity and Metabolism, 26(5), 1897-1907. https://doi.org/10.1111/dom.15506
Vancouver
Tu WJ, Zhao Z, Yan F, Zeng X, Li J. Geographic and ethnicity variation in the prevalence of middle‐aged and elderly adult obesity in China in 2020. Diabetes, Obesity and Metabolism. 2024;26(5):1897-1907. doi:10.1111/dom.15506
BibTeX
@article{Tu2024,
author = {Tu, Wen-Jun and Zhao, Zhenping and Yan, Feng and Zeng, Xianwei and Li, Jilai},
title = {Geographic and ethnicity variation in the prevalence of middle‐aged and elderly adult obesity in China in 2020},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {5},
pages = {1897--1907},
doi = {10.1111/dom.15506}
}
EUVIMED